AMGN Jan 2025 230.000 put
| Previous close | 3.5000 |
| Open | 4.7000 |
| Bid | 4.5500 |
| Ask | 4.9000 |
| Strike | 230.00 |
| Expiry date | 2025-01-17 |
| Day's range | 4.7000 - 4.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | 538 |
PR NewswireAMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
Amgen (NASDAQ:AMGN) today announced the presentation of new data from its broad oncology portfolio at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting, taking place from May 31-June 4 in Chicago. The 17 abstracts from Amgen-sponsored and partner-led studies, including one late-breaking oral presentation, demonstrate Amgen's commitment to innovation and meaningfully improving outcomes for people living with difficult-to-treat cancers.
ZacksBeat the Market the Zacks Way: EverQuote, Micron, Amgen in Focus
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
ZacksAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
